Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Psycho-Oncology|September 13, 2022
Emotional functioning during bereavement after the death of patients with advanced cancer and associated factorsLaurien Ham, Heidi P Fransen, Janneke van Roij, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
Patient Satisfaction and Quality of Life Before and After Treatment of Pancreatic and Periampullary Cancer: A Prospective Multicenter StudyTara M Mackay, Lennart B van Rijssen, Jurr O Andriessen, et al.
Cancers|August 23, 2019
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with CabazitaxelIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
The British Journal of Surgery|May 27, 2023
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapyStefi Nordkamp, Floor Piqeur, Kim van den Berg, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
The Oncologist|September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled studyFloris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
Drugs|January 12, 2023
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface MalignanciesNiels A D Guchelaar, Bo J Noordman, Stijn L W Koolen, et al.
Eclinicalmedicine|February 4, 2025
Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort studyAnne M Gehrels, Pauline A J Vissers, Mirjam A G Sprangers, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2020
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysisAnouk E J Latenstein, Tara M Mackay, Geert-Jan Creemers, et al.
Annals of Surgical Oncology|January 24, 2026
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II TrialTeun B M van den Heuvel, Paulien Rauwerdink, Emma Hulshof, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Psycho-Oncology|September 13, 2022
Emotional functioning during bereavement after the death of patients with advanced cancer and associated factorsLaurien Ham, Heidi P Fransen, Janneke van Roij, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
Patient Satisfaction and Quality of Life Before and After Treatment of Pancreatic and Periampullary Cancer: A Prospective Multicenter StudyTara M Mackay, Lennart B van Rijssen, Jurr O Andriessen, et al.
Cancers|August 23, 2019
Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with CabazitaxelIngeborg E de Kruijff, Anieta M Sieuwerts, Wendy Onstenk, et al.
The British Journal of Surgery|May 27, 2023
Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapyStefi Nordkamp, Floor Piqeur, Kim van den Berg, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
The Oncologist|September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled studyFloris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
Drugs|January 12, 2023
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface MalignanciesNiels A D Guchelaar, Bo J Noordman, Stijn L W Koolen, et al.
Eclinicalmedicine|February 4, 2025
Longitudinal health-related quality of life in patients with pancreatic cancer stratified by treatment: a nationwide cohort studyAnne M Gehrels, Pauline A J Vissers, Mirjam A G Sprangers, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2020
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysisAnouk E J Latenstein, Tara M Mackay, Geert-Jan Creemers, et al.
Annals of Surgical Oncology|January 24, 2026
Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II TrialTeun B M van den Heuvel, Paulien Rauwerdink, Emma Hulshof, et al.
Pageof 10